Information
-
Trademark
-
87278810
-
Serial Number
87278810
-
Registration Number
5857855
-
International Classifications
-
Filing Date
December 22, 2016
7 years ago
-
Registration Date
September 10, 2019
5 years ago
-
Transaction Date
September 10, 2024
3 months ago
-
Status Date
September 10, 2019
5 years ago
-
Published for Opposition Date
May 30, 2017
7 years ago
-
Location Date
August 02, 2019
5 years ago
-
First Use Anywhere Date
February 26, 2019
5 years ago
-
First Use In Commerce Date
February 26, 2019
5 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
FERRAIUOLO, DOMINIC
-
Attorney Docket Number
304146022000
Attorney Name
Jennifer Lee Taylor
Law Office Assigned Location Code
L20
-
Owners
Mark Drawing Code
3
Mark Identification
T
Case File Statements
- DM0000: The mark consists of a stylized letter "T" with the top left half in the color red, forming the left edge of a triangle that is red with a dot in the middle in the color white and that includes within it the top right and bottom of the letter "T" in white.
- GS0051: Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
- CC0000: The color(s) red and white is/are claimed as a feature of the mark.
Case File Event Statements
-
3/22/2017 - 7 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
12/27/2016 - 7 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/6/2017 - 7 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/7/2017 - 7 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
3/28/2017 - 7 years ago
7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
3/28/2017 - 7 years ago
5 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
3/28/2017 - 7 years ago
6 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
1/20/2018 - 6 years ago
17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
3/28/2017 - 7 years ago
8 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
3/28/2017 - 7 years ago
9 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/10/2017 - 7 years ago
10 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/30/2017 - 7 years ago
11 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/30/2017 - 7 years ago
12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/25/2017 - 7 years ago
13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
1/18/2018 - 6 years ago
14 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/18/2018 - 6 years ago
15 - SOU EXTENSION 1 FILED
Type: EXT1
-
1/18/2018 - 6 years ago
16 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
7/9/2019 - 5 years ago
27 - TEAS STATEMENT OF USE RECEIVED
Type: EISU
-
3/28/2018 - 6 years ago
18 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Type: ASCK
-
6/27/2018 - 6 years ago
19 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/27/2018 - 6 years ago
20 - SOU EXTENSION 2 FILED
Type: EXT2
-
6/27/2018 - 6 years ago
21 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
6/29/2018 - 6 years ago
22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
1/16/2019 - 5 years ago
23 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
1/16/2019 - 5 years ago
24 - SOU EXTENSION 3 FILED
Type: EXT3
-
1/16/2019 - 5 years ago
25 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
1/18/2019 - 5 years ago
26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
7/9/2019 - 5 years ago
29 - USE AMENDMENT FILED
Type: IUAF
-
7/29/2019 - 5 years ago
28 - CASE ASSIGNED TO INTENT TO USE PARALEGAL
Type: AITU
-
7/30/2019 - 5 years ago
30 - STATEMENT OF USE PROCESSING COMPLETE
Type: SUPC
-
8/2/2019 - 5 years ago
31 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Type: CNPR
-
9/10/2019 - 5 years ago
33 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
9/10/2024 - 3 months ago
34 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Type: REM1
-
8/3/2019 - 5 years ago
32 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Type: SUNA